Bayer Diagnostics strikes deal with AmeriNet:
This article was originally published in Clinica
The diagnostics division of German pharmaceutical company Bayer has entered into a three-year agreement with AmeriNet for clinical systems for both urinalysis and immunodiagnostics. AmeriNet is one of the largest membership-based group purchasing organisations in the US, representing 4,500 member facilities or 300,000 hospital beds.
You may also be interested in...
US investigators fan out to non-China inspection priorities and Secretary Azar talks supply management; warning letters hit record keeping, investigations and basic GMP compliance.
Mallinckrodt to pay $1.6bn and place its generics unit in bankruptcy under agreement in principle for US global settlement; six states are not on board, including New York, whose suit is still set to go to trial March 20.
The company has reached a broad opioid settlement agreement in principle under which its specialty generics subsidiaries would file for Chapter 11 bankruptcy and Mallinckrodt's branded business would operate separately.